These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 168908)

  • 1. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
    Jackson DM
    J Pharm Pharmacol; 1975 Apr; 27(4):278-80. PubMed ID: 239123
    [No Abstract]   [Full Text] [Related]  

  • 4. Central action of narcotic analgesics. Part III. The role of endogenous noradrenaline in hyperactivity induced by morphine or fentanyl in mice.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1978; 30(4):537-47. PubMed ID: 216979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of beta-phenylethylamine on temperature in mice and its possible mechanisms of action.
    Jackson DM
    Arzneimittelforschung; 1975 May; 25(5):776-80. PubMed ID: 1242322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

  • 7. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
    Dourish CT
    Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholaminergic control of thyrotropin secretion.
    Montoya E; Wilber JF; Lorincz M
    J Lab Clin Med; 1979 May; 93(5):887-94. PubMed ID: 219126
    [No Abstract]   [Full Text] [Related]  

  • 10. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
    Dunstan R; Jackson DM
    Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.
    Handley SL; Thomas KV
    Psychopharmacology (Berl); 1978 Jul; 58(3):283-8. PubMed ID: 98799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.
    Vanderwolf CH; Robinson TE; Pappas BA
    Brain Res; 1980 Nov; 202(1):65-77. PubMed ID: 6968619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 15. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.
    Bailey RC; Jackson DM
    Psychopharmacology (Berl); 1978 Apr; 56(3):317-26. PubMed ID: 418441
    [No Abstract]   [Full Text] [Related]  

  • 16. Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.
    Dunstan R; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):153-6. PubMed ID: 209350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aliphatic monoamines on motor activity of mice: no direct interaction with dopaminergic D2 receptor.
    Widy-Tyszkiewicz E; Członkowski A
    Pol J Pharmacol Pharm; 1983; 35(6):467-72. PubMed ID: 6234517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-methyldopamine as a dopaminergic agonist.
    Duvoisin RC; Marsden CD
    Adv Neurol; 1975; 9():243-8. PubMed ID: 1146655
    [No Abstract]   [Full Text] [Related]  

  • 19. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of LSD on locomotor activity in reserpinized mice.
    Grabowska M; Antikiewicz L; Michaluk J
    Pol J Pharmacol Pharm; 1974; 26(5):499-504. PubMed ID: 4427810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.